Cincinnati.Com
NKY.COM  |  ENQUIRER  |  CIN WEEKLY  |  Classifieds  |  Cars  |  Homes  |  Jobs  |  Help
Currently:
27°F
Light Snow
Weather | Traffic
The Enquirer
HOME
NEWS
ENTERTAINMENT
SPORTS
REDS
BENGALS
LOCAL GUIDE
MULTIMEDIA
ARCHIVES
SEARCH
 
 TODAY'S ENQUIRER 
 Front Page 
 Local News 
 Sports 
-- Business 
 Editorials 
 Tempo 
 Home Style 
 Travel 
 Health 
 Technology 
 Weather 
 Back Issues 
 Search 
 Subscribe 

 SPORTS 
 Bearcats 
 Bengals 
 High School 
 Reds 
 Xavier 

 VIEWPOINTS 
 Jim Borgman 
 Columnists 
 Readers' views 

 ENTERTAINMENT 
 Movies 
 Dining 
 Horoscopes 
 Lottery Results 
 Local Events 
 Video Games 

 CINCINNATI.COM 
 Giveaways 
 Maps/Directions 
 Send an E-Postcard 
 Coupons 
 Visitor's Guide 
 Web Directory 

 CLASSIFIEDS 
 Jobs 
 Cars 
 Homes 
 General 
 Place an ad 

 HELP 
 Feedback 
 Subscribe 
 Search 
 Newsroom Directory 



 
Friday, August 03, 2001

Generic version of Prozac debuts




By Theresa Agovino
The Associated Press

        NEW YORK — Barr Laboratories Inc. on Thursday began shipping its version of Prozac, the hugely successful drug that revolutionized the treatment of depression, in the biggest generic drug launch ever.

        Indianapolis-based Eli Lilly and Co.'s last valid patent for Prozac expired Thursday, paving the way for the Food and Drug Administration to grant final approval of Barr's product. The generic should be available for sale today.

        Barr, which is in the midst of buying Cincinnati's Duramed Pharmaceuticals, won't specify how much the generic Prozac will cost, but said the price will be between 25 and 40 percent lower than the daily cost of $2.63. That means the approximately 2 million people taking Prozac will save up to $383 each annually. The drug is available by prescription only.

        Prozac generated $2.6 billion in sales for Lilly in 2000 and is the biggest selling drug to ever go off patent. It became a blockbuster because it lacks the harsh side effects of earlier depression medicines, an advancement that spurred more doctors to prescribe the medicine and consequently ended some of the taboo surrounding mental illness.

        A six-year battle over rights to Prozac ended last week when a U.S. district judge in Indianapolis issued an order invalidating a patent that would have protected Lilly's monopoly until December 2003.

        The judge's action followed the refusal of the U.S. Court of Appeals in Washington, D.C., to rehear Lilly's appeal. Lilly still plans to appeal to the U.S. Supreme Court but conceded that it is highly unlikely to succeed.

        “I feel like an expectant father. We've done all the work and now all we do is wait,” said Bruce Downey, Barr's chairman and chief executive said in an interview earlier this week.

        Barr's plant in Forest, Va., has been working 10 hours a day, six days a week, since February to manufacture the 150 million capsules for the launch of fluoxetine, the generic name for Prozac.

        It ordered about $4 million of new equipment for the facility and has a logistics strategy set up to fill orders within three days.

        Typically, it takes Barr three weeks to fully launch a drug.

       



Armor, O'Gara make plans
Radio ads suddenly a bit cheaper
Flood cleanup backs up
N. Ky. putting the 'knew' in New Economy
- Generic version of Prozac debuts
Industry notes: Manufacturing
Shares fall after loss at American Financial posted
Business Digest
Morning Memo
Tristate Summary
What's the Buzz?

 

Latest Headline News
Updated Every 30 Minutes
BUSINESS NEWS

U.S. Rises in Auto Reliability Ratings

Congolese Shun Own Currency for Dollars

Delta Air Lines Posts $52M Profit in 3Q

Prepared Holiday Meals Up in Popularity

Christmas Returns to Wal-Mart Marketing


Cincinnati.Com
Search our site by keyword:  
Search also: News | Jobs | Homes | Cars | Classifieds | Obits | Coupons | Events | Dining
Movies/DVDs | Video Games | Hotels | Golf | Visitor's Guide | Maps/Directions | Yellow Pages

  CINCINNATI.COM  |  NKY.COM  |  ENQUIRER  |  CIN WEEKLY  |  Classifieds  |  Cars  |  Homes  |  Jobs  |  Help


Search | Questions/help | News tips | Letters to the editors | Subscribe
Newspaper advertising | Web advertising | Place a classified | Circulation

Copyright 1995-2007. The Cincinnati Enquirer, a Gannett Co. Inc. newspaper.
Use of this site signifies agreement to terms of service updated 12/19/2002.